AX-2026-1601-JRGTv2
Lipo-C Advanced (LC216) 216mg · Lot LC216-216MG-260622-3AH · VidaPeps
CRYPTOGRAPHICALLY SEALED
SHA-384: 421be9bb159c3bcf
Scan to verify
PRODUCT ATTRIBUTION
VidaPeps logo
VidaPeps
VidaPeps LLC
vidapeps.com
Brand identity verified
Submitted by: VidaPeps LLC

Originated by VidaPeps LLC, which attests it authorized this test as the brand of record.

Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.

Open / Print PDF
SAMPLE & VIAL VALIDATION
Validated vial
Vial as received & analyzed
BrandVidaPeps
ProductLipo-C Advanced (LC216) 216mg
Lot / BatchLC216-216MG-260622-3AH
Label Claim216 mg
Matrixsolution
Sample Count1
Cap ColorTan
Crimp ColorGray
Contents ColorRed
Seal IntactYes
Conditionsealed, intact
// LAYER 1: LC-MS/MS (ESI+)

Molecular Mass Fingerprinting

pass· validated in house
Identity confirmed
L-Methionine (primary lipotropic active of Lipo-C Advanced)
THEORETICAL
149.21 Da
OBSERVED
149.06 Da
ERROR
-0.15 Da
Mass spectrum trace not retained for this certificate. Identity is confirmed by accurate mass (error within tolerance).

Molecular mass fingerprinting confirms the identity of the primary active L-Methionine (average neutral MW 149.21 Da; observed deconvoluted neutral mass 149.06 Da, ESI+ [M+H]+ at m/z 150.06). Variance of 0.15 Da is well within the 1.0 Da tolerance. Consistent with a Lipo-C (MIC) lipotropic formulation: L-Methionine plus Inositol and Choline, with L-Carnitine and B-complex cofactors present in the matrix and detected as expected co-components.

REVIEW & DIGITAL SIGNATURES
Analyst
Alana Reeves
ed25519:db0ee5b9f29e931264283c75...
Technical Reviewer
Michael Niles
ed25519:996a81b03aa1fa1cc941a624...
Laboratory Director
Daniel Brennan
ed25519:3f3f9f5a8701899206066bc9...
Released Jul 1, 2026, 05:02 UTC
This report is immutable. Any alteration breaks the cryptographic seal. Verify independently at /verify/AX-2026-1601-JRGT
RESEARCH USE ONLY

All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.

LIMITATION OF LIABILITY

To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.